Acknowledgements
der
DER
This research is funded by a grant from Pink Ribbon, the Netherlands (2012.WO43.C158), awarded to Dr. M.L. van der Lee. We are grateful to the patients for their participation in this trial and to oncology nurses, nurse practitioners, and oncologists from the Maasstad hospital in Rotterdam, St. Antonius hospital in Utrecht, Admiraal de Ruyter hospital in Vlissingen, Reinier de Graaf hospital in Delft, Antonius hospital in Sneek, Elisabeth TweeSteden Ziekenhuis in Tilburg, Catharina hospital in Eindhoven, and University Medical Center Groningen (all situated in the Netherlands) for informing patients about the trial. We would like to thank Eltica de Jager Meezenbroek, Irma Manuputy, Mirjam Koppenol, and Iris Verschoor for their administrative support.